Cervical cancer remains one of the deadliest diseases for Filipino women, with nearly 7 out of 10 patients dying within a year of diagnosis due to late detection and limited treatment access.
To change this reality, the Centralized Laboratory Model for HPV DNA Screening (CLAMS) introduced a new way of reaching women with lifesaving screening and care.
Rolled out in five Metro Manila cities between 2023 and 2024, the pilot project showcased a model that can scale nationwide.
Here are the eight biggest takeaways from the CLAMS initiative:
1. Early Detection through HPV DNA Testing
Unlike traditional Pap smears and VIA methods, HPV DNA testing detects high-risk infections before they progress into cancer. This shift means women can be treated earlier, dramatically improving survival rates.
2. Self-Sampling Empowers Women
One of CLAMS’ most transformative elements is self-collection of cervical samples. Women no longer need to undergo uncomfortable clinical procedures. Instead, they can take specimens themselves, reducing stigma and barriers to participation.
3. Centralized Labs Increase Accuracy
Collected samples are sent to high-capacity central laboratories for advanced PCR testing. This hub-and-spoke system ensures efficiency, high-volume processing, and reliable results without needing costly hospital-based setups.
4. Thermal Ablation at the Point of Care
Beyond screening, CLAMS integrates same-day treatment for pre-cancerous lesions through thermal ablation. This immediate response prevents delays that could allow disease progression.
5. Strong Multi-Sector Collaboration
The pilot succeeded thanks to partnerships among local government units, health offices, Jhpiego, Cancer Warriors Foundation, and the Healthcare Technology Association of the Philippines. This collective approach strengthens sustainability.
6. Real Impact in Metro Manila
The 18-month project was deployed in Manila, Quezon City, Navotas, Taguig, and Muntinlupa. By embedding services within local health systems, women accessed screening closer to their homes.
7. Phase 2 Expansion Beyond the Capital
Building on its success, the next phase aims to reach 10,000 women in Cebu, Davao City, and Taguig. It will also improve patient follow-ups, digitize health data, and expand provider training for wider clinical governance.
8. A Roadmap Toward Nationwide Elimination
With fewer than 1% of Filipino women currently receiving regular screening, CLAMS provides a scalable and integrated model. It offers the blueprint for eliminating cervical cancer across the Philippines.
The CLAMS pilot has proven that innovation, accessibility, and collaboration can save lives. If expanded nationwide, it could change the future of women’s health in the Philippines forever.
Leave a Reply